“After losing friends on October 7th, I didn’t recognize myself. I came in hesitant — I came out a different person. The darkness has faded.”
- Netanel Elmalich. Commando Fighter · Egoz Unit
The solution.
A
Proven efficacy in our own cohorts.
~80% PTSD remission across two cohorts of Israeli combat soldiers (N=26, Dec 2025 + Feb 2026). Results exceed published outcomes for conventional first-line treatments.
B
A 12-day retreat with 3–4 guided psychedelic assisted therapy sessions produces measurable symptom reduction rom baseline through one-month follow-up across PTSD, depression, anxiety and insomnia.
Rapid and durable results.
C
Favorable safety profile:
Psilocybin is non-addictive and well-tolerated under clinical supervision. Our protocol includes full medical screening, licensed psychiatric oversight, and real-time monitoring.
D
Beyond symptom control:
Soldiers report restored emotional regulation, reconnection with family, and renewed sense of purpose — outcomes that conventional medicine rarely achieves.
science-backed · clinically monitored · community-grounded